Skip to main content

Advertisement

SpringerLink
Log in

Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992–2003

  • Original Article
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

Carisoprodol is commonly prescribed as a centrally acting muscle relaxant, but it is also subject to abuse. The literature describing fatal intoxications with the drug is limited to a relatively small number of cases, and there are inconsistencies with regard to which concentration levels that are toxic. We therefore investigated all forensic autopsies at the Norwegian Institute of Public Health during the period 1992–2003 where carisoprodol was detected. The median concentrations of carisoprodol in intoxication with carisoprodol only or with only minor other analytical findings was 36 mg/l (range 8–65 mg/l; n=5). In the rest of the intoxications, the relevance of carisoprodol relative to the other drugs detected was variable (n=93). When the number of intoxications with carisoprodol each year were divided by the number of defined daily doses (DDD) sold, a fatal toxicity index between 5.6 and 6.9 deaths/1 million DDD was obtained. The total number of cases where carisoprodol was detected increased during the period studied, which correlated to sales figures for the drug. We conclude that carisoprodol can be fatal in concentrations below those indicated in some of the previously published literature. There were, however, only a small number of cases where the cause of death can be attributed to use of carisoprodol alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Dalen P, Alvan G, Wakelkamp M, Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6:387–394

    Article  PubMed  CAS  Google Scholar 

  2. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM (2003) Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 28:1978–1992

    Article  PubMed  Google Scholar 

  3. Hindle TH III (1972) Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med 117:7–11

    PubMed  Google Scholar 

  4. Boyles W, Glassmann J, Soyka J (1983) Management of acute muskuloskeletal conditions: thoracolumbar strain and pain. A double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Today’s Ther Trends 1:1–16

    Google Scholar 

  5. Rollings H, Glassmann J, Soyka J (1982) Management of acute muskuloskeletal conditions—thoracolumbar strain and sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzadrine hydrochloride. Curr Ther Res 34:917–928

    Google Scholar 

  6. Boothby L, Doering P, Hatton R (2003) Carisoprodol: a marginally effective skeletal muscle relaxant with serious abuse potential. Hosp Pharm 38:337–345

    Google Scholar 

  7. Wyller TB, Korsmo G, Gadeholt G (1991) Dependence on carisoprodol (Somadril)? A prospective withdrawal study among prisoners [Avhengig av karisoprodol (Somadril)? En prospektiv seponeringsundersøkelse blant fengselsinnsatte]. Tidsskr Nor Laegeforen 111:193–195

    PubMed  CAS  Google Scholar 

  8. Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM (1999) Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis 18:51–56

    Article  PubMed  CAS  Google Scholar 

  9. Bailey DN, Briggs JR (2002) Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 117:396–400

    Article  PubMed  CAS  Google Scholar 

  10. Sikdar S, Basu D, Malhotra AK, Varma VK, Mattoo SK (1993) Carisoprodol abuse: a report from India. Acta Psychiatr Scand 88:302–303

    PubMed  CAS  Google Scholar 

  11. Bramness JG, Morland J, Sorlid HK, Rudberg N, Jacobsen D (2005) Carisoprodol intoxications and serotonergic features. Clin Toxicol 43:39–45

    Google Scholar 

  12. Siddiqi M, Jennings CA (2004) A near-fatal overdose of carisoprodol (SOMA): case report. J Toxicol Clin Toxicol 42:239–240

    Article  PubMed  Google Scholar 

  13. Roth BA, Vinson DR, Kim S (1998) Carisoprodol-induced myoclonic encephalopathy. J Toxicol Clin Toxicol 36:609–612

    Article  PubMed  CAS  Google Scholar 

  14. Roberge RJ, Lin E, Krenzelok EP (2000) Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 18:61–64

    Article  PubMed  CAS  Google Scholar 

  15. Roache JD, Griffiths RR (1987) Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 243:978–988

    PubMed  CAS  Google Scholar 

  16. Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122:107–123

    Article  PubMed  CAS  Google Scholar 

  17. Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79–87

    PubMed  Google Scholar 

  18. Chung H, Park M, Hahn E, Choi H, Choi H, Lim M (2004) Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 1025:458–464

    Article  PubMed  Google Scholar 

  19. Backer RC, Zumwalt R, McFeeley P, Veasey S, Wohlenberg N (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. J Anal Toxicol 14:332–334

    PubMed  CAS  Google Scholar 

  20. Adams HR, Kerzee T, Morehead CD (1975) Carisoprodol-related death in a child. J Forensic Sci 20:200–202

    PubMed  CAS  Google Scholar 

  21. Davis GG, Alexander CB (1998) A review of carisoprodol deaths in Jefferson County, Alabama. South Med J 91:726–730

    PubMed  CAS  Google Scholar 

  22. Ronning M (2001) Drug consumption in Norway 1996–2000 [Legemiddelforbruket i Norge 1996–2000], Norwegian Medicinal Depot, Oslo

  23. Ronning M, Sanner T, Boe GH, Litleskare I, Strøm H, Granum T (2005) Drug consumption in Norway 2000–2004 [Legemiddelforbruket i Norge 2000–2004], Norwegian Institute of Public Health, Oslo

  24. Oydvin K, Ronning M, Sakshaug S, Blix H, Ullerud T (1997) Drug consumption in Norway 1992–1996 [Legemiddelforbruket i Norge 1992–1996], Norsk Medisinaldepot AS, Oslo

  25. TIAFT (2006) http://www.tiaft.org/tmembers/ttvidx.html. Cited 7 Feb 2006

  26. Micomedex (2006) http://www.thomsonhc.com/hcs/librarian/PFPUI/Tq4CzCw1heeLZm. Micromedex. Cited 7 Feb 2006

  27. Reith DM, Fountain J, McDowell R, Tilyard M (2003) Comparison of the fatal toxicity index of zopiclone with benzodiazepines. J Toxicol Clin Toxicol 41:975–980

    Article  PubMed  CAS  Google Scholar 

  28. Hilberg T, Rogde S, Morland J (1999) Postmortem drug redistribution—human cases related to results in experimental animals. J Forensic Sci 44:3–9

    PubMed  CAS  Google Scholar 

  29. Hilberg T, Morland J, Bjorneboe A (1994) Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 64:47–55

    Article  PubMed  CAS  Google Scholar 

  30. Pelissier-Alicot AL, Gaulier JM, Dupuis C et al (2006) Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med 120:226–232

    Article  PubMed  Google Scholar 

  31. Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52:895–911

    PubMed  CAS  Google Scholar 

  32. Olsen H, Koppang E, Alvan G, Morland J (1994) Carisoprodol elimination in humans. Ther Drug Monit 16:337–340

    Article  PubMed  CAS  Google Scholar 

  33. Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Morland J (2005) The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects. Eur J Clin Pharmacol 61:499–506

    Article  PubMed  CAS  Google Scholar 

  34. Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151–347

    PubMed  CAS  Google Scholar 

  35. Steentoft A, Teige B, Ceder G et al (2001) Fatal poisoning in drug addicts in the Nordic countries. Forensic Sci Int 123:63–69

    Article  PubMed  CAS  Google Scholar 

  36. Jonsson A, Holmgren P, Ahlner J (2004) Fatal intoxications in a Swedish forensic autopsy material during 1992–2002. Forensic Sci Int 143:53–59

    Article  PubMed  CAS  Google Scholar 

  37. Morland J (2000) Driving under the influence of medication and various substances other than alcohol [Kjøring under påvirkning av medikamenter og andre rusmidler enn alkohol]. Tidsskr Nor Laegeforen 120:2148–2150

    PubMed  CAS  Google Scholar 

  38. Meel BL (2004) Incidence and patterns of violent and/or traumatic deaths between 1993 and 1999 in the Transkei region of South Africa. J Trauma 57:125–129

    Article  PubMed  CAS  Google Scholar 

  39. Qin P, Agerbo E, Westergard-Nielsen N, Eriksson T, Mortensen PB (2000) Gender differences in risk factors for suicide in Denmark. Br J Psychiatry 177:546–550

    Article  PubMed  CAS  Google Scholar 

  40. Demetriades D, Gkiokas G, Velmahos GC, Brown C, Murray J, Noguchi T (2004) Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. J Am Coll Surg 199:687–692

    Article  PubMed  Google Scholar 

  41. Bramness JG, Skurtveit S, Grung M, Morland J (2000) Centrally acting muscle relaxants and traffic hazards [Sentralt virkende muskelrelakserende midler i trafikken]. Tidsskr Nor Laegeforen 120:1966–1969

    PubMed  CAS  Google Scholar 

  42. Substance Abuse and Mental Health Service Administration (2003) Emergency department trends from the drug abuse warning network, final estimates 1995–2002. DAWN Series D-24, Rockville, MD

    Google Scholar 

  43. Koski A, Vuori E, Ojanpera I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 119:344–348

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Jørgen G. Bramness

    Present address: Division of Epidemiology, Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway

Authors and Affiliations

  1. Division of Forensic Toxicology and Drug Abuse, Norwegian Institute of Public Health, P.O. Box 4404, Nydalen, 0403, Oslo, Norway

    Gudrun Høiseth, Jørgen G. Bramness, Asbjørg S. Christophersen & Jørg Mørland

Authors
  1. Gudrun Høiseth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jørgen G. Bramness
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Asbjørg S. Christophersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jørg Mørland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gudrun Høiseth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Høiseth, G., Bramness, J.G., Christophersen, A.S. et al. Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992–2003. Int J Legal Med 121, 403–409 (2007). https://doi.org/10.1007/s00414-006-0139-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-006-0139-1

Keywords

Search

Navigation